HCPCS Level II code G0102 denotes a prostate cancer screening performed by digital rectal examination. This screening code represents a preventive clinical service used to identify potential prostate abnormalities that may warrant further diagnostic evaluation. As a nationally relevant preventive procedure, this code intersects with primary care and urology practice patterns and preventive care coverage policies across major payers.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage considerations, common billing modifiers (listed separately), and the clinical context for use of the code. The publication outlines how G0102 is used in outpatient and physician office settings for routine prostate cancer screening and highlights typical documentation elements and encounter settings.

The report provides benchmarks and policy-related summaries to inform billing and administrative teams about coding expectations and where to seek payer-specific guidance. Data not available in the input is noted where applicable.